Last reviewed · How we verify
NCT02640105: CHAD
Cluster Headache, Addictions and Vascular Function
trial testing Neurological clinical examination in Cluster Headache in 95 participants. Completed in 10 June 2016.
10 June 2016
Quick facts
| Lead sponsor | University Hospital, Bordeaux |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 95 |
| Start date | 25 June 2014 |
| Primary completion | 10 June 2016 |
| Estimated completion | 10 June 2016 |
| Sites | 1 location across France |
Drugs / interventions tested
- Neurological clinical examination
- Psychological clinical examination
- Questionnaires
- Blood sample — full drug profile →
- Endothelial function measurement
Conditions studied
- Cluster Headache — all drugs for Cluster Headache →
Sponsor
University Hospital, Bordeaux
Who can join
18 and older, any sex, with Cluster Headache. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cluster headache (CH) is one of the most painful primitive headaches. Developments in neuroimaging have demonstrated activation of the ipsilateral hypothalamic and orexinergic system, which is similar in patients with addictions. CH has strong links to the vascular system but there is no study measuring endothelial function in CH sufferers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02640105
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cluster Headache
Currently open trials in the same condition.
- NCT06540651 — Efficacy of Light Therapy in Treatment of Chronic Cluster Headache · NA · recruiting
- NCT06277063 — nVNS for the Prevention and Treatment of Primary Headache · NA · recruiting
- NCT06503328 — Role of Specific microRNAs in Cluster Headache · recruiting
- NCT04406259 — Atrioventricular Block and Cluster Headache (SEVA) · Phase 4 · active not recruiting
- NCT04939922 — China Headache and Vertigo Registry Study · recruiting
Other University Hospital, Bordeaux trials
Trials by the same sponsor.
- NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
- NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
- NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
- NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
- NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02640105 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
- Last refreshed: 31 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02640105.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing